ONEBIO LABS / RESEARCH INFORMATION
IGF-1 LR3
Research Protein Analogue | Long R3 Igf-1
Technical specifications
| Classification | Modified insulin-like growth factor-1 analogue |
|---|---|
| Common name | Long R3 IGF-1 / IGF-1 LR3 |
| Modification | Extended N-terminus with Arg substitution; exact construct per COA |
| Form | Lyophilised research protein |
| Identity / purity | Refer to batch-specific COA |
| Purity / testing | Refer to product-specific batch COA / analytical documentation |
| Intended use | Laboratory and research purposes only |
Exact sequence, molecular mass and counter-ion should be taken from the supplier's batch-specific analytical documentation.
01 / PRODUCT INFORMATION
Product description
IGF-1 LR3 is a modified analogue of insulin-like growth factor-1 designed for experimental research with altered binding characteristics and persistence compared with native IGF-1. It is studied in cellular growth, differentiation and metabolic signalling models.
02 / RESEARCH CONTEXT
Research overview
Research areas: IGF-1 receptor signalling; cellular proliferation and differentiation; protein metabolism; metabolic research.
03 / PRODUCT INFORMATION
ONE BIOLABS quality
ONE BIOLABS provides research products with product information and available batch documentation where applicable. Batch-specific identity, purity, concentration, salt form, testing and manufacturing claims should be stated only where supported by the applicable Certificate of Analysis or other analytical documentation.
04 / STORAGE
Refrigerate at 2–8°C
Unless the product-specific label or Certificate of Analysis states otherwise, store refrigerated at 2–8°C, protected from direct light, excessive heat and moisture. Keep the container securely closed. Product-specific storage instructions and stability data should take precedence.
Important notice
FOR RESEARCH PURPOSES ONLY. This product information is intended for laboratory and research reference. Products described in this document are not intended for human consumption, self-administration, diagnosis, treatment, prevention or cure of disease unless supplied as an appropriately authorised medicinal product through lawful channels. No dosage, administration or therapeutic guidance is provided.
Research findings, especially preclinical findings, should not be interpreted as proof of human safety or efficacy.
Reviews
There are no reviews yet.